Gemzar

Gemzar: an effective medicine in the fight against cancer

Gemzar is a synthetic anticancer drug that is used to treat various types of cancer. The drug is produced by a French pharmaceutical group and is supplied under the Eli Lilly brand. It contains an active substance called gemcitabine.

The dosage form of Gemzar is presented in the form of a lyophilized powder for the preparation of an injection solution. The drug is available in ampoules of 5 ml and 10 ml.

Gemzar is indicated for the treatment of several types of cancer, including bladder cancer, non-small cell lung cancer, and pancreatic cancer. It can be used both in monotherapy and in combination with other antitumor agents.

The drug is recommended for the treatment of patients whose cancer has already spread to other parts of the body, as well as for the treatment of patients whose cancer progresses after initial therapy.

Gemzar has several contraindications. The drug is not recommended for use in patients with hypersensitivity to gemcitabine, in the presence of severe impairment of liver and kidney function, as well as in children and pregnant women.

Like any drug, Gemzar may cause side effects. They can manifest themselves both from the cardiovascular system and blood (anemia, hypotension, myocardial infarction), and from the respiratory system (bronchospastic reactions), gastrointestinal tract (nausea, vomiting, diarrhea) and skin (rash, itching).

Depending on the dose and indications for use, side effects may be more or less pronounced.

In general, Gemzar is an effective medicine in the fight against cancer. It may be prescribed as first-line therapy for the treatment of lung and pancreatic cancer, as well as for the treatment of other types of cancer. However, before using Gemzar, you should consult your doctor and read the instructions for use of the drug.